Navigation Links
Scientists move towards stem cell therapy trials to mend shattered bones
Date:2/18/2008

The UK Stem Cell Foundation, the Medical Research Council and Scottish Enterprise, in partnership with the Chief Scientists Office, are funding a 1.4 million project to further the research at the University of Edinburgh with a view to setting up a clinical trial within two years.

The initiative could have a major impact on treating conditions such as osteoarthritis as well as treating trauma victims whose bones have been shattered beyond repair.

It involves using a bioactive scaffold made to protect the stem cells and simulate their growth into bone or cartilage once they are placed in the affected area. The scaffold consists of a fairly rigid mesh structure, coated or impregnated with a drug that affects the patients cells.

Dr Brendon Noble, of the University of Edinburghs MRC Centre for Regenerative Medicine, said: This is a novel approach in terms of treating damaged bones and cartilage. The aim is to translate the knowledge we have gained from bone biology studies into tangible treatments for patients.

Researchers will also work with clinicians, headed by Hamish Simpson, professor of orthopaedics and trauma at the University of Edinburgh, with a view to eventually translating their findings into treatments for patients.

As well as using cells derived from bone marrow, the scientists will work in collaboration with the Scottish National Blood Transfusion Service to culture bone forming cells derived from blood.

The advantage of these blood-sourced cells is that they can be extracted without the need for surgery. The use of a patients own stem cells means that they are also unlikely to be rejected.

Dr Anna Krassowska, research manager for the UK Stem Cell Foundation said: In the UK hip fractures kill 14,000 elderly people every year - more than many cancers. The worldwide market for orthopaedic devices alone represents some $17 billion. This research has the potential not only to impact on
'/>"/>

Contact: Tara Womersley
tara.womersley@ed.ac.uk
01-316-509-836
University of Edinburgh
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... Move over shave cream. ... men and barbershops are scrambling to meet it. , Reports published this year (Mintel ... and haircare. But the data also reflects that men are getting more done at ...
(Date:8/31/2015)... ... 2015 , ... A year ago this month, Seniors Guide first hit stands ... issue commemorating the successful first year. , “We started the magazine with the ... in their lives,” says Melissa Wolfert, founding Publisher for Seniors Guide Columbus. “Making the ...
(Date:8/31/2015)... ... 2015 , ... Chicago-based company The Mood Factory, with brand ... and awareness for breast and ovarian health. During September and October, The ... to Bright Pink® to encourage households, dorms, and offices around the U.S. to ...
(Date:8/31/2015)... ... ... It’s a lot like coming home. Life-long Fox Valley resident James Holbrook has been ... the job, he’s run into residents of the retirement community who he’s known since ... in such a wonderful place,” he said. GreenFields, which is sponsored by Friendship Senior ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... networking and relationship-marketing firm, announced today the nominees vying for the 2015 ... U.S. Region. Executives include top-ranking decision makers representing national to global organizations ...
Breaking Medicine News(10 mins):Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 2Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 3Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 3Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 2Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 3Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:T.E.N. Announces Nominees for the 2015 ISE® Northeast Awards; People's Choice voting now open 2Health News:T.E.N. Announces Nominees for the 2015 ISE® Northeast Awards; People's Choice voting now open 3Health News:T.E.N. Announces Nominees for the 2015 ISE® Northeast Awards; People's Choice voting now open 4
... New research has found that hormone therapy used to treat ... chance of developing various heart problems. Some choices of therapy ... Researchers told Europe,s biggest cancer congress, ECCO 15 ESMO ... findings of their study, the largest and most comprehensive to ...
... , MAHWAH, N.J., Sept. 22 Radware ... application delivery solutions for business-smart networking, today announced ... and South Carolina, has leveraged Radware,s suite of application delivery solutions ... load balancing capabilities for its extensive hospital system. ...
... , , RANDOLPH, Mass., Sept. 22 ... to serving individuals with Autism Spectrum Disorders (ASD), today released its ... and adolescents with ASD ever published. , , ... information about the myriad treatments available for ASD," said Susan M. ...
... Germany, September 22 The,Gerresheimer Group expands its ... significant investments in the USA and,Europe. This week ... research,and development center for medical plastic systems in ... for pharmaceutical plastic packaging in Spain.,"Plastics are increasingly ...
... Corrie Yackulic, ... after nearly twenty years to open her own personal injury law practice. , ... Seattle, Wash. (Lexis Nexis) September 22, 2009 ... at personal injury law firm Schroeter Goldmark & Bender to launch her own personal injury ...
... ... Pelvic Organ Prolapse --provides helpful information about the common conditions of urinary incontinence and ... symptoms, as well as the symptoms of pelvic organ prolapse. Finally, treatment options are ... ...
Cached Medicine News:Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 2Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 3Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 4Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 2Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 3Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 4Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 5Health News:National Autism Center Releases Groundbreaking Report on Autism Treatments 2Health News:National Autism Center Releases Groundbreaking Report on Autism Treatments 3Health News:Gerresheimer Expands in the Global Pharmaceutical Plastic Business 2Health News:Gerresheimer Expands in the Global Pharmaceutical Plastic Business 3Health News:Seattle Personal Injury Attorney Corrie Yackulic Opens Law Firm, Unveils New Website 2Health News:Women's Pelvic Organ Prolapse and Incontinence Guide Informs, Outlines Treatments 2Health News:Women's Pelvic Organ Prolapse and Incontinence Guide Informs, Outlines Treatments 3
(Date:8/31/2015)... 31, 2015 BioLight ... BLGTY) ("BioLight" or the "Company"), a firm that ... ophthalmology and cancer diagnostics, today announced that its ... identified several new genetic markers with high potential ... treated with bisphosphonate drugs and was able to ...
(Date:8/31/2015)... 31, 2015  Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today it has completed enrollment of the additional ... (DRC) earlier this year, into the company,s Phase ... innate defense regulator (IDR) and is being evaluated ...
(Date:8/31/2015)... , Aug. 31, 2015  Asterias Biotherapeutics, Inc. ... the emerging field of regenerative medicine, today announced ... Chicago -based Rush University Medical ... activity of escalating doses of AST-OPC1 (oligodendrocyte progenitor ... motor complete cervical spinal cord injury (SCI). This ...
Breaking Medicine Technology:BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6
... experienced,clinical benefit when treated with daily RAD001 and monthly Sandostatin LAR ... Depot, - 77% of patients with pancreatic NET experienced clinical ... treated with daily RAD001, - Data show RAD001, an oral mTOR ... ...
... Inc.,(Nasdaq: BNVI ) today announced the publishing ... Society for Pharmacology and Experimental Therapeutics, Drug,Metabolism and ... Bioactive Compound Isolated from the Chinese Herbal,Selective Estrogen ... the active compounds of MF101, Bionovo,s drug,candidate for ...
Cached Medicine Technology:RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 2RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 3RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 4RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 5RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 6RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 7Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 3
BETADINE® Surgical Scrub is a microbicidal, sudsing cleanser that promptly kills most bacteria, fungi, viruses, protozoa and yeasts. It is indicated for hand hygiene, surgical hand-scrubbing, an...
... Topical, Bactericide, Microbicide for professional ... technology in skin disinfectants combining quaternary ... a synergistic blend of emollients and ... and gram-positive organisms tested in 30 ...
... bonds with the skin ... germ-killing field. In addition ... antimicrobial effect, HIBICLENS' non-drying, ... promotes compliance with the ...
... solution, allows the user to prep one ... in less than 2-minutes. It also utilizes ... surgical scrubbing and healthcare personnel handwashing. ACTIPREP ... provide a tacky surface for drapes to ...
Medicine Products: